Necrotizing Otitis Externa: A Systematic Review and Analysis of Changing Trends.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
23
6
2020
medline:
15
4
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
To assess for changes in trends of the disease process, management, and outcomes of necrotizing otitis externa (NOE) over the last decade. Articles in English, published between January 2011 and June 2019, were searched in PubMed, Scopus, Web of Science, ScienceDirect, and the Cochrane Database. Inclusion criteria: 1) reported evidence of NOE, 2) details on patient demographic and underlying medical disorder, 3) details on treatments, 4) documented outcomes, and 5) greater than 10 cases. Study demographics, underlying conditions, infectious etiology, treatments, signs and symptoms, and outcomes. Ten studies, totalling 284 patients with a mean age of 67.8 years, were included. The time period of collected patient data ranged from 2000 to 2018. Temporal subgroup analysis was conducted before and after 2009. Cure rate was lower in the post-2009 group (76.0 versus 94.1%, p < 0.01) while disease-specific mortality remained stable. Increases in proportions of diabetes and culture negative results (p < 0.01) were also observed in this latter group. Rate of extensive surgery and the use of ciprofloxacin decreased (p < 0.01), while the use of ceftazidime increased in the post-2009 group (p < 0.01). A decrease in cure rate of NOE patients was observed in the setting of an increase in prevalence of diabetes. Various antipseudomonal agents are being used and an increase in culture negative results is seen.
Identifiants
pubmed: 32569149
doi: 10.1097/MAO.0000000000002723
pii: 00129492-202009000-00002
doi:
Substances chimiques
Ciprofloxacin
5E8K9I0O4U
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1004-1011Références
Ali T, Meade K, Anari S, et al. Malignant otitis externa: Case series. J Laryngol Otol 2010; 124:846–851.
Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004; 4:34–39.
Jacobsen LM, Antonelli PJ. Errors in the diagnosis and management of necrotizing otitis externa. Laryngoscope 2010; 120: (suppl 4): S207.
Marina S, Goutham MK, Rajeshwary A, et al. A retrospective review of 14 cases of malignant otitis externa. J Otol 2019; 14:63–66.
Omran AA, El Garem HF, Al Alem RK. Recurrent malignant otitis externa: management and outcome. Eur Arch Otorhinolaryngol 2012; 269:807–811.
Giamarellou H. Malignant otitis externa: The therapeutic evolution of a lethal infection. J Antimicrob Chemother 1992; 30:745–751.
Sharma S, Corrah T, Singh A. Management of necrotizing otitis externa: Our experience with forty-three patients. J Int Adv Otol 2017; 13:394–398.
Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am 2008; 41:537–549.
Roglic G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis 2016; 1:3–8.
Sylvester MJ, Sanghvi S, Patel VM, et al. Malignant otitis externa hospitalizations: Analysis of patient characteristics. Laryngoscope 2017; 127:2328–2336.
Hutson KH, Watson GJ. Malignant otitis externa, an increasing burden in the twenty-first century: Review of cases in a UK teaching hospital, with a proposed algorithm for diagnosis and management. J Laryngol Otol 2019; 133:356–362.
Stern Shavit S, Bernstine H, Sopov V, et al. FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis. Laryngoscope 2019; 129:961–966.
Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist 1950; 21:607–611.
Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046–1055.
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629–634.
Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343:d4002.
Bock K, Ovesen T. Optimised diagnosis and treatment of necrotizing external otitis is warranted. Dan Med Bull 2011; 58:A4292.
Guevara N, Mahdyoun P, Pulcini C, et al. Initial management of necrotizing external otitis: Errors to avoid. Eur Ann Otorhinolaryngol Head Neck Dis 2013; 130:115–121.
Honnurappa V, Ramdass S, Mahajan N, et al. Effective inexpensive management of necrotizing otitis externa is possible in resource-poor settings. Ann Otol Rhinol Laryngol 2019; 128:848–854.
Singh J, Bhardwaj B. The role of surgical debridement in cases of refractory malignant otitis externa. Indian J Otolaryngol Head Neck Surg 2018; 70:549–554.
Williams SP, Curnow TL, Almeyda R. Lessons learnt from the diagnosis and antimicrobial management of necrotising (malignant) otitis externa: Our experience in a tertiary referral centre. B-ENT 2014; 10:99–104.
Lambor DV, Das CP, Goel HC, et al. Necrotising otitis externa: clinical profile and management protocol. J Laryngol Otol 2013; 127:1071–1077.
Soudry E, Joshua BZ, Sulkes J, et al. Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg 2007; 133:1002–1004.
Chen YA, Chan KC, Chen CK, et al. Differential diagnosis and treatments of necrotizing otitis externa: A report of 19 cases. Auris Nasus Larynx 2011; 38:666–670.
Stern Shavit S, Soudry E, Hamzany Y, et al. Malignant external otitis: Factors predicting patient outcomes. Am J Otolaryngol 2016; 37:425–430.
Djalilian HR, Shamloo B, Thakkar KH, et al. Treatment of culture-negative skull base osteomyelitis. Otol Neurotol 2006; 27:250–255.
Slattery WH 3rd, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am 1996; 29:795–806.
Eveleigh MO, Hall CE, Baldwin DL. Prognostic scoring in necrotising otitis externa. J Laryngol Otol 2009; 123:1097–1102.
Shelton JC, Antonelli PJ, Hackett R. Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg 2002; 126:76–78.
Hanna E, Hughes G, Eliachar I, et al. Fungal osteomyelitis of the temporal bone: A review of reported cases. Ear Nose Throat J 1993; 72:532537–541.
Verim A, Naiboglu B, Karaca CT, et al. Clinical outcome parameters for necrotizing otitis externa. Otol Neurotol 2014; 35:371–376.
Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev 2005; CD004617.
Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev 2013; CD004617.
Lucente FE, Parisier SC, Som PM. Complications of the treatment of malignant external otitis. Laryngoscope 1983; 93:279–281.
Davis JC, Gates GA, Lerner C, et al. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992; 118:89–93.
Prasanna Kumar S, Ravikumar A, Somu L, et al. Malignant otitis externa: An emerging scourge. J Clin Gerontol Geriatr 2013; 4:128–131.
Spielmann PM, Yu R, Neeff M. Skull base osteomyelitis: Current microbiology and management. J Laryngol Otol 2013; 127:S8–S12.
Hobson CE, Moy JD, Byers KE, et al. Malignant otitis externa: Evolving pathogens and implications for diagnosis and treatment. Otolaryngol Head Neck Surg 2014; 151:112–116.
Kaya I, Sezgin B, Eraslan S, et al. Malignant otitis externa: A retrospective analysis and treatment outcomes. Turk Arch Otorhinolaryngol 2018; 56:106–110.
Honnurappa V, Ramdass S, Mahajan N, et al. Effective inexpensive management of necrotizing otitis externa is possible in resource-poor settings. Ann Otol 2019; 128:848–854.
Courson AM, Vikram HR, Barrs DM. What are the criteria for terminating treatment for necrotizing (malignant) otitis externa? Laryngoscope 2014; 124:361–362.
Loh S, Loh WS. Malignant otitis externa: An Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg 2013; 148:991–996.
Hasibi M, Ashtiani MK, Motassadi Zarandi M, et al. A treatment protocol for management of bacterial and fungal malignant external otitis: A large cohort in Tehran, Iran. Ann Otol Rhinol Laryngol 2017; 126:561–567.
Bhat V, Aziz A, Bhandary SK, et al. Malignant otitis externa—a retrospective study of 15 patients treated in a tertiary healthcare center. J Int Adv Otol 2015; 11:72–76.